Why are pharma companies leaving so much to chance? Read more
In March 2014, medical device company, Invendo Medical, closed a US$28m financing round led by new investor Xeraya Capital Read more
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI Read more
Government continues to subvert the efficiency of technology. Read more
Dr. Rath Research Institute: Revolutionary new concept of heart disease threatens end of global statin market Read more
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting Read more
In the first study of its kind, researchers have demonstrated novel and previously unknown mechanisms of action Read more
The study, revealed today, looks into the use of mobile health apps. Read more
All seven research projects are in line with the roadmap of the Dutch Top Sector. Read more
